July 8, 2010 USA
Immunologic findings in Clinical Immunology
Immunologic data from Diamyd’s Phase II study in children and adolescents recently diagnosed with type 1 diabetes have been published on-line in Clinical Immunology (Article in Press, Corrected Proof).
The title of the paper is “GAD-alum treatment in patients with type 1 diabetes and the subsequent effect on GADA IgG subclass distribution, GAD65 enzyme activity and humoral response”.
Read the abstract here
Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.